The Innovative Medicines Fund (IMF), set up in the UK last year to fast-track NHS access to promising new drugs, still hasn't provided any funding for a new medicine, and
The UK Government has said it will provide £210 million in funding for a project that will track 'superbugs' in Africa and Asia, to curtail the threat posed by antimicrobi
An attempt by the British Generic Manufacturers Association (BGMA) to get a seat at the negotiation table for the new Voluntary Scheme for Branded Medicines Pricing and Ac
ABPI partnerships director Brian Duggan considers the role that partnerships with industry have played in the last 75 years of the NHS, and how those partnerships can help the NHS face the